TNSN92115A1 - Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation - Google Patents

Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation

Info

Publication number
TNSN92115A1
TNSN92115A1 TNTNSN92115A TNSN92115A TNSN92115A1 TN SN92115 A1 TNSN92115 A1 TN SN92115A1 TN TNSN92115 A TNTNSN92115 A TN TNSN92115A TN SN92115 A TNSN92115 A TN SN92115A TN SN92115 A1 TNSN92115 A1 TN SN92115A1
Authority
TN
Tunisia
Prior art keywords
preparation
benzimidazoles
substitutes
compounds
intermediates
Prior art date
Application number
TNTNSN92115A
Other languages
English (en)
Inventor
Bjorn Christer Holstein Kark
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN92115A1 publication Critical patent/TNSN92115A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Abstract

LA PRESENTE INVENTION PORTE SUR DE NOUVEAUX COMPOSES AYANT UNE ACTIVITE THERAPEUTIQUE, INTERMEDIAIRES POUR LEUR PREPARATION, PROCEDES DE LEUR PREPARATION, FORMULATIONS PHARMACEUTIQUES CONTENANT LESDITS COMPOSES ET UTILISATION MEDICALE DESDITS COMPOSES ET DE COMPOSES CONNUS ANALOGUES
TNTNSN92115A 1991-12-19 1992-12-18 Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation TNSN92115A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103776A SE9103776D0 (sv) 1991-12-19 1991-12-19 New compounds

Publications (1)

Publication Number Publication Date
TNSN92115A1 true TNSN92115A1 (fr) 1993-06-08

Family

ID=20384667

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92115A TNSN92115A1 (fr) 1991-12-19 1992-12-18 Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation

Country Status (25)

Country Link
EP (1) EP0628049A1 (fr)
JP (1) JPH07502503A (fr)
KR (1) KR940703840A (fr)
CN (1) CN1031827C (fr)
AP (1) AP397A (fr)
AU (1) AU665043B2 (fr)
CA (1) CA2124689A1 (fr)
CZ (1) CZ146794A3 (fr)
FI (1) FI942912A (fr)
HR (1) HRP921400A2 (fr)
HU (1) HUT68270A (fr)
IL (1) IL104025A0 (fr)
IS (2) IS4079A (fr)
MA (1) MA22746A1 (fr)
MX (1) MX9207269A (fr)
NO (1) NO942230L (fr)
NZ (1) NZ246220A (fr)
SE (1) SE9103776D0 (fr)
SI (1) SI9200402A (fr)
SK (1) SK73594A3 (fr)
TN (1) TNSN92115A1 (fr)
TW (1) TW224100B (fr)
WO (1) WO1993012124A1 (fr)
YU (1) YU101692A (fr)
ZA (1) ZA928836B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19645974C1 (de) * 1996-11-07 1998-08-13 Andreas Johannes Kesel (Z)-5-[[3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylen]-2-thioxo-4- thiazolidinon, Verfahren zu dessen Herstellung und Verwendung
WO1999033846A2 (fr) * 1997-12-31 1999-07-08 The University Of Kansas Remedes contenant des precurseurs hydrosolubles d'amines secondaires et tertiaires, et leurs procedes d'obtention
ATE467637T1 (de) 2005-07-28 2010-05-15 Intervet Int Bv Neue benzimidazol(thio)carbamate mit antiparasitischer wirkung und ihre synthese
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
PL2037914T3 (pl) 2006-06-14 2014-04-30 Intervet Int Bv Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
MX365051B (es) 2014-11-26 2019-05-09 Univ Mexico Nac Autonoma Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
WO1991019712A1 (fr) * 1990-06-20 1991-12-26 Aktiebolaget Astra Derives de dialcoxy-pyridinyle-benzimidazole, procede de preparation et utilisation pharmaceutique de ces derives

Also Published As

Publication number Publication date
MA22746A1 (fr) 1993-07-01
AU3175293A (en) 1993-07-19
TW224100B (fr) 1994-05-21
CN1073446A (zh) 1993-06-23
FI942912A0 (fi) 1994-06-17
NO942230D0 (no) 1994-06-14
AP397A (en) 1995-08-14
ZA928836B (en) 1993-07-05
HUT68270A (en) 1995-06-28
YU101692A (sh) 1995-10-03
HU9401840D0 (en) 1994-09-28
AU665043B2 (en) 1995-12-14
MX9207269A (es) 1993-06-01
IS4079A (is) 1993-06-20
CA2124689A1 (fr) 1993-06-24
KR940703840A (ko) 1994-12-12
SE9103776D0 (sv) 1991-12-19
NZ246220A (en) 1996-02-27
HRP921400A2 (en) 1994-08-31
SI9200402A (en) 1993-06-30
EP0628049A1 (fr) 1994-12-14
CN1031827C (zh) 1996-05-22
SK73594A3 (en) 1995-02-08
FI942912A (fi) 1994-06-17
AP9200463A0 (en) 1993-01-31
JPH07502503A (ja) 1995-03-16
NO942230L (no) 1994-06-14
CZ146794A3 (en) 1996-02-14
IL104025A0 (en) 1993-05-13
IS3960A (is) 1993-06-20
WO1993012124A1 (fr) 1993-06-24

Similar Documents

Publication Publication Date Title
Seltzer et al. Flare-ups in endodontics: I. Etiological factors
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
UY23665A1 (es) Procedimiento para la preparacion de compuesto farmaceutico
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
LV12766A (lv) Composition of l-dopa esters
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69510190D1 (de) Verwendung von fettsäureester als bioklebstoffe
YU215090A (sr) Formulacija u obliku pilule za kontrolisano oslobađanje
RU94026283A (ru) Фармацевтическое соединение
ES8800946A1 (es) Un procedimiento para preparar derivados de guanina
ATE268605T1 (de) Pharmazeutische akzeptabel dnase zusammensetzung
CA2392165A1 (fr) Analogues de la vitamine d
TNSN92115A1 (fr) Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
JPS62265222A (ja) 細胞膜の脂質構造および機能の修飾法並びにこれに使用する製剤組成物
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법